02192.HK
Medlive Technology Co., Ltd.
HKSE · Healthcare · Medical - Distribution · CN
HKD 6.31
−0.32%Year over year
Reported trailing growth
- Revenue
- +2.9%
- EBITDA
- +43.4%
- EBIT
- +97.1%
- EPS
- +4.5%
- Free cash flow
- +103.0%
- Operating cash flow
- +76.8%
Forward estimates
Based on analyst estimates
- Revenue
- -45.8%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +26.9%
- EBITDA
- +9.2%
- EBIT
- +82.3%
- Net income
- +41.8%
- EPS
- +41.2%
- Free cash flow
- +20.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026